Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Pacira Biosciences Inc PCRX

Pacira BioSciences, Inc. is a holding company for Pacira Pharmaceuticals, Inc. The Company's non-opioid treatments include EXPAREL (bupivacaine liposome injectable suspension), which is a long-acting, local analgesic for postsurgical pain management; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), which is an extended-release, intra-articular (IA), corticosteroid... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:PCRX)

Shareholders of Pacira BioSciences, Inc. Should Contact Levi & Korsinsky Before March 14, 2025 to Discuss Your Rights - PCRX

Accesswire 4 hours ago

The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Case Against Pacira BioSciences, Inc.

Accesswire 6 hours ago

Shareholders that lost money on Pacira BioSciences, Inc.(PCRX) should contact Levi & Korsinsky about pending Class Action - PCRX

Accesswire 7 hours ago

Faruqi & Faruqi Reminds Pacira Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 14, 2025 - PCRX

Newsfile 8 hours ago

Pacira BioSciences Strengthens Executive Leadership Team with Two Key Appointments

GlobeNewswire 9 hours ago

March 14, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against PCRX

Accesswire 10 hours ago

PCRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire 10 hours ago

Pacira BioSciences, Inc. Class Action: Levi & Korsinsky Reminds Pacira Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 14, 2025 - PCRX

PR Newswire 12 hours ago

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Pacira BioSciences, Inc.(PCRX) Shareholders

Accesswire 20 hours ago

Bullboard Posts (NDAQ:PCRX)

Pacira BioSciences, Inc. Announces Proposed Offering of $250

JUST IN: $PCRX Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior...
whytestocks - May 8, 2024